tiprankstipranks
Analyst Profile
Followed by 53 other investors
.
Brian Tanquilut

Brian Tanquilut

Jefferies
Wall Street Analyst
Ranked #998 out of 8,047 Analysts on TipRanks (#1,699 out of 21,521 overall experts)

Success Rate

56%
216 out of 385 Profitable Transactions

Average Return

6.40%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied Brian Tanquilut's ratings since 2010 and opened each position for the duration of 1 Year:
56.10% of your transactions would have been profitable with an average return of 6.4%

Stock Rating Distribution

614Ratings
72.64% Buy
27.04% Hold
0.33% Sell
Distribution of Brian Tanquilut's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Surgery Partners Inc.
(SGRY)
Rating Type:Buy
Dates:Jul 24, 2020 - Jul 24, 2021
Gain:257.70%
The most profitable rating made by Brian Tanquilut

Brian Tanquilut's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Sabra Healthcare REIT
May 25, 2010
Buy
Assigned
$11.00
(-33.53% Downside)
0.00%
1
HS
HealthSpring
Oct 24, 2011
Buy
Reiterated
100%
+2.40%
1
LNCR
Lincare Holdings Inc.
Jul 09, 2012
Hold
Downgraded
100%
+22.00%
2
~HMA
Health Management
Jul 10, 2013
Buy
Reiterated
50%
-6.75%
2
CTRX
Catamaran
Apr 07, 2015
Hold
Downgraded
50%
+11.95%
10
IPCM
IPC Healthcare
Aug 06, 2015
Hold
Downgraded
100%
+37.60%
8
Global Cord Blood
Aug 10, 2015
Buy
Reiterated
$11.00
(311.99% Upside)
67%
+21.40%
4
Owens & Minor
Feb 16, 2016
Hold
Reiterated
$36.00
(1.21% Upside)
0.00%
1
ACADIA Pharmaceuticals
Apr 26, 2016
Buy
Reiterated
$85.00
(418.29% Upside)
100%
+3.10%
1
Option Care Health
Nov 29, 2016
Buy
Reiterated
$2.50
(-92.81% Downside)
0%
-35.90%
4
List of latest recommendations made by Brian Tanquilut. Click to expand and see Brian Tanquilut's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More